Chinese Journal of Stroke ›› 2024, Vol. 19 ›› Issue (2): 219-226.DOI: 10.3969/j.issn.1673-5765.2024.02.015
Previous Articles Next Articles
XU Yaning1,2, ZHANG Meng1
Received:
2022-11-04
Online:
2024-02-20
Published:
2024-02-20
Contact:
ZHANG Meng, E-mail: zhangmeng@tmmu.edu.cn
许亚宁1,2,张猛1
通讯作者:
张猛 zhangmeng@tmmu.edu.cn
基金资助:
CLC Number:
XU Yaning, ZHANG Meng. Research Progress of Anticoagulation Therapy during Perioperative Period for Endovascular Treatment of Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2024, 19(2): 219-226.
许亚宁, 张猛. 急性缺血性卒中血管内治疗围手术期抗凝治疗研究进展[J]. 中国卒中杂志, 2024, 19(2): 219-226.
[1] WANG Y J,LI Z X,GU H Q,et al. China stroke statistics:an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases,China National Clinical Research Center for Neurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol,2022,7(5):415-450. [2] WRIGHT I S,MCDEVITT E. Cerebral vascular diseases:their significance,diagnosis and present treatment,including the selective use of anticoagulant substances[J]. Ann Intern Med,1954,41(4):682-698. [3] SANDERCOCK P A,COUNSELL C,KANE E J. Anticoagulants for acute ischaemic stroke [J/OL]. Cochrane Database Syst Rev,2015,2015(3):CD000024[2022-10-01]. https://doi.org/10.1002/14651858.CD000024. pub4. [4] SANDERCOCK P A,LEONG T S. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke[J/OL]. Cochrane Database Syst Rev,2017,4(4):CD000119[2022-10-01]. https://doi.org/10.1002/14651858.CD000119.pub4. [5] SMYTHE M A,PARKER D,GARWOOD C L,et al. Timing of initiation of oral anticoagulation after acute ischemic stroke in patients with atrial fibrillation[J]. Pharmacotherapy,2020,40(1):55-71. [6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志,2018,51(9):666-682. Chinese Society of Neurology,Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol,2018,51(9):666-682. [7] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2022-10-01]. https://doi.org/10.1161/STR. 0000000000000211. [8] BERKHEMER O A,FRANSEN P S,BEUMER D,et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med,2015,372(1):11-20. [9] CAMPBELL B C,MITCHELL P J,KLEINIG T J,et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med,2015,372(11):1009-1018. [10] GOYAL M,DEMCHUK A M,MENON B K,et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med,2015,372(11):1019-1030. [11] JOVIN T G,CHAMORRO A,COBO E,et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med,2015,372(24):2296-2306. [12] SAVER J L,GOYAL M,BONAFE A,et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295. [13] BEREKASHVILI K,SOOMRO J,SHEN L,et al. Safety and feasibility of argatroban,recombinant tissue plasminogen activator,and intra-arterial therapy in stroke(ARTSS-IA study)[J]. J Stroke Cerebrovasc Dis,2018,27(12):3647-3651. [14] MAC GRORY B,HOLMES D N,MATSOUAKA R A,et al. Recent vitamin K antagonist use and intracranial hemorrhage after endovascular thrombectomy for acute ischemic stroke[J]. JAMA,2023,329(23):2038-2049. [15] UPHAUS T,SINGER O C,BERKEFELD J,et al. Safety of endovascular treatment in acute stroke patients taking oral anticoagulants[J]. Int J Stroke,2017,12(4):412-415. [16] KÜPPER C,FEIL K,WOLLENWEBER F A,et al. Endovascular stroke treatment in orally anticoagulated patients:an analysis from the German stroke registry-endovascular treatment[J]. J Neurol,2021,268(5):1762-1769. [17] GOLDHOORN R B,VAN DE GRAAF R A,VAN REES J M,et al. Endovascular treatment for acute ischemic stroke in patients on oral anticoagulants:results from the MR CLEAN Registry[J]. Stroke,2020,51(6):1781-1789. [18] LEKER R R,FARRAJ A,SACAGIU T,et al. Atrial fibrillation treatment adequacy and outcome after endovascular thrombectomy[J/OL]. J Stroke Cerebrovasc Dis,2020,29(8):104948[2022-10-01]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104948. [19] DEL ZOPPO G J,HIGASHIDA R T,FURLAN A J,et al. PROACT:a phase Ⅱ randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke[J]. Stroke,1998,29(1):4-11. [20] NAHAB F,WALKER G A,DION J E,et al. Safety of periprocedural heparin in acute ischemic stroke endovascular therapy:the Multi MERCI trial[J]. J Stroke Cerebrovasc Dis,2012,21(8):790-793. [21] WINNINGHAM M J,HAUSSEN D C,NOGUEIRA R G,et al. Periprocedural heparin use in acute ischemic stroke endovascular therapy:the TREVO 2 trial[J]. J Neurointerv Surg,2018,10(7):611-614. [22] VAN DE GRAAF R A,CHALOS V,VAN ES A C G M,et al. Periprocedural intravenous heparin during endovascular treatment for ischemic stroke:results from the MR CLEAN Registry[J]. Stroke,2019,50(8):2147-2155. [23] BENALI F,HINSENVELD W H,VAN DER LEIJ C,et al. Effect of heparinized flush concentration on safety and efficacy during endovascular thrombectomy for acute ischemic stroke:results from the MR CLEAN Registry[J]. Cardiovasc Intervent Radiol,2021,44(5):750-755. [24] VAN DER STEEN W,VAN DE GRAAF R A,CHALOS V,et al. Safety and efficacy of aspirin,unfractionated heparin,both,or neither during endovascular stroke treatment(MR CLEAN-MED):an open-label,multicentre,randomised controlled trial[J]. Lancet,2022,399(10329):1059-1069. [25] ENOMOTO Y,YOSHIMURA S,EGASHIRA Y,et al. The risk of intracranial hemorrhage in Japanese patients with acute large vessel occlusion; subanalysis of the RESCUE-Japan Registry[J]. J Stroke Cerebrovasc Dis,2016,25(5):1076-1080. [26] HEBERT S,CLAVEL P,MAIER B,et al. Benefits and safety of periprocedural heparin during thrombectomy in patients contra-indicated for alteplase[J/OL]. J Stroke Cerebrovasc Dis,2020,29(10):105052[2022-10-01]. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105052. [27] DESILLES J P,SYVANNARATH V,DI MEGLIO L,et al. Downstream microvascular thrombosis in cortical venules is an early response to proximal cerebral arterial occlusion[J/OL]. JAHA,2018,7(5):e007804 [2022-10-01]. https://doi.org/10.1161/JAHA.117.007804. [28] DA ROS V,SCAGGIANTE J,SALLUSTIO F,et al. Carotid stenting and mechanical thrombectomy in patients with acute ischemic stroke and tandem occlusions:antithrombotic treatment and functional outcome[J]. AJNR Am J Neuroradiol,2020,41(11):2088-2093. [29] ZHU F,PIOTIN M,STEGLICH-ARNHOLM H,et al. Periprocedural heparin during endovascular treatment of tandem lesions in patients with acute ischemic stroke:a propensity score analysis from TITAN registry[J]. Cardiovasc Intervent Radiol,2019,42(8):1160-1167. [30] GOYAL M,MENON B K,VAN ZWAM W H,et al. Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials[J]. Lancet,2016,387(10029):1723-1731. [31] ALBERS G W,MARKS M P,KEMP S,et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718. [32] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med,2018,378(1):11-21. [33] YANG P F,ZHANG Y W,ZHANG L,et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J]. N Engl J Med,2020,382(21):1981-1993. [34] LECOUFFE N E,KAPPELHOF M,TREURNIET K M,et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke[J]. N Engl J Med,2021,385(20):1833-1844. [35] MITCHELL P J,YAN B,CHURILOV L,et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset:an open-label,blinded-endpoint,randomised non-inferiority trial[J]. Lancet,2022,400(10346):116-125. [36] NG F C,CHURILOV L,YASSI N,et al. Prevalence and significance of impaired microvascular tissue reperfusion despite macrovascular angiographic reperfusion(no-reflow)[J/OL]. Neurology,2022, 98(8):e790-e801[2022-10-01]. https://doi.org/10.1212/WNL.0000000000013210. [37] KIM J,YI H J,LEE D H,et al. Safety and feasibility of using argatroban immediately after mechanical thrombectomy for large artery occlusion[J/OL]. World Neurosurgery,2019,132:e341-e349[2022-10-01]. https://doi.org/10.1016/j.wneu.2019.08.151. [38] MATSUBARA H,ENOMOTO Y,EGASHIRA Y,et al. The safety and efficacy of periprocedural intravenous anticoagulants for acute ischemic stroke patients who underwent endovascular treatment:sub-analysis of the RESCUE-Japan Registry 2[J/OL]. J Neurol Sci,2022,442:120390[2022-10-01]. https://doi.org/10.1016/j.jns.2022.120390. [39] KIRCHHOF P,BENUSSI S,KOTECHA D,et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962. [40] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J]. 中华神经科杂志,2022,55(10):1071-1110. Chinese Society of Neurology,Chinese Stroke Society. Chinese guideline for the secondary prevention of ischemic stroke and transient ischemic attack 2022[J]. Chin J Neurol,2022,55(10):1071-1110. [41] MA H R,CHE R W,ZHANG Q H,et al. The optimum anticoagulation time after endovascular thrombectomy for atrial fibrillation-related large vessel occlusion stroke:a real-world study[J]. J Neurol,2023,270(4):2084-2095. [42] XU Y N,LIU C C,LI W,et al. Efficacy and safety of early anticoagulation after endovascular treatment in patients with atrial fibrillation[J]. Stroke Vasc Neurol,2023,8(5):405-412. |
[1] | LI Aiyuan, FAN Ping, LI Xianjun, ZHAO Zhe, ZHAN Tongxia, XIE Hai. The Predictive Value of 18F-FDG PET/CT on Acute Ischemic Stroke in Patients with Active Cancer [J]. Chinese Journal of Stroke, 2024, 19(2): 150-157. |
[2] | FU Chunling, SONG Biying, YANG Dahui. Relationship between Visual Impairment and Cognitive Function in Elderly Patients with Post-Stroke Mild Cognitive Impairment [J]. Chinese Journal of Stroke, 2024, 19(2): 167-172. |
[3] | LUO Dong, LI Guoliang, WEN Huijun, WANG Junwen. Predictive Value of Systemic Immune-Inflammatory Index on Post-Stroke Depression in Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(2): 190-196. |
[4] | MO Chenglong, WANG Simin, HOU Le, PENG Liebiao, WANG Rongfei, SHI Haishan, ZHENG Dong. Cerebral Venous Sinus Thrombosis Associated with Hyperthyroidism: A Case Report#br# [J]. Chinese Journal of Stroke, 2024, 19(2): 207-212. |
[5] | ZENG Chaokun, ZHAO Zhenqiang. Research Progress of the Correlation between Variation in the Circle of Willis and Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(2): 213-218. |
[6] | JIANG Xiaoqing, LI Zixiao, WANG Yongjun. Progress in Clinical Research of Medical Quality Improvement in Stroke [J]. Chinese Journal of Stroke, 2024, 19(2): 227-234. |
[7] | WANG Yongjun, XIONG Yunyun, LI Guangshuo, CAO Zhixin, WANG Wenjie, YAN Ran, WANG Liyuan, LU Zhengzhao, HAO Manjun. Highlights in Stroke in 2023 [J]. Chinese Journal of Stroke, 2024, 19(1): 1-21. |
[8] | WANG Jing, LI Zixiao, DONG Qiang, ZHAO Xingquan. Interpretation of Medical Quality Control Indicators for Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(1): 50-54. |
[9] | YANG Jiaxin, HE Chunyu, LIU Lei, CHEN Wenbo, XIE Yan. Prediction Models of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: A Systematic Review [J]. Chinese Journal of Stroke, 2024, 19(1): 76-86. |
[10] | KANG Zhiming, MEI Bin. Clinical Advances in Hemorrhagic Transformation after Mechanical Thrombectomy for Acute Ischemic Stroke due to Large Vessel Occlusion [J]. Chinese Journal of Stroke, 2024, 19(1): 94-104. |
[11] | ZHANG Xinmiao, XU Man, DING Lingling, JING Jing, GONG Xiping, DONG Kehui, ZHAO Xingquan, WANG Yongjun, LI Zixiao. Research on the Influence of Cerebrovascular Disease Clinical Decision Support System on the Key Performance Indicators of Medical Care Quality for Stroke [J]. Chinese Journal of Stroke, 2024, 19(1): 120-124. |
[12] | XU Yuming. Stroke Center Construction and Quality Control: A Long Way to Go [J]. Chinese Journal of Stroke, 2023, 18(9): 973-977. |
[13] | GAO Yuan, LIU Kai, LI Yapeng, YANG Zongyu, LI Yusheng, SONG Bo, XU Yuming. Research Progress of the Construction and Quality Control of Stroke Center [J]. Chinese Journal of Stroke, 2023, 18(9): 979-985. |
[14] | LI Yapeng, GAO Yuan, LIU Kai, YANG Zongyu, WANG Jingjing, ZHOU Lue, DONG Xiaokang, LI Yusheng, SONG Bo, XU Yuming. Exploration and Practice of the Construction of Stroke Center in Henan Province [J]. Chinese Journal of Stroke, 2023, 18(9): 986-992. |
[15] | WU Di, JING Jing, PAN Yuesong, CHEN Xuzhu, ZHAO Xingquan. Relationship between Characteristics of Ischemic Infarction Distribution and Involved Vascular Segments in Patients with Ischemic Stroke Caused by Spontaneous Carotid Artery Dissection [J]. Chinese Journal of Stroke, 2023, 18(9): 993-1000. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||